India's cardiac and anti-diabetes drugs market has surged over threefold in the past decade, reaching ₹30,000 crore and ₹17,000 crore respectively. Innovative medicines and loss of patents have driven growth, with several brands now contributing significantly to market turnover.
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.